nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—nephron—nephrolithiasis	0.196	0.436	CbGeAlD
Ingenol Mebutate—PRKCD—Effects of PIP2 hydrolysis—DGKH—nephrolithiasis	0.0748	0.136	CbGpPWpGaD
Ingenol Mebutate—PRKCD—renal system—nephrolithiasis	0.0698	0.155	CbGeAlD
Ingenol Mebutate—PRKCD—cortex of kidney—nephrolithiasis	0.0657	0.146	CbGeAlD
Ingenol Mebutate—PRKCA—Acetylcholine regulates insulin secretion—CHRM3—nephrolithiasis	0.0647	0.117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Endothelin Pathways—ADCY10—nephrolithiasis	0.0599	0.109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—nephron tubule—nephrolithiasis	0.0423	0.0942	CbGeAlD
Ingenol Mebutate—PRKCA—renal system—nephrolithiasis	0.0385	0.0856	CbGeAlD
Ingenol Mebutate—PRKCA—kidney—nephrolithiasis	0.0372	0.0827	CbGeAlD
Ingenol Mebutate—PRKCD—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0266	0.0482	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Myometrial Relaxation and Contraction Pathways—RGS14—nephrolithiasis	0.0257	0.0467	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0153	0.0277	CbGpPWpGaD
Ingenol Mebutate—PRKCD—G alpha (q) signalling events—DGKH—nephrolithiasis	0.015	0.0272	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—RGS14—nephrolithiasis	0.0148	0.0268	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0134	0.0243	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.0131	0.0238	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.013	0.0236	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.0126	0.0229	CbGpPWpGaD
Ingenol Mebutate—PRKCD—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.0108	0.0196	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00994	0.018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—AQP1—nephrolithiasis	0.00993	0.018	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00968	0.0176	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00769	0.014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00752	0.0137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00745	0.0135	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—SLC7A9—nephrolithiasis	0.00675	0.0123	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—DGKH—nephrolithiasis	0.00675	0.0123	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—RGS14—nephrolithiasis	0.00631	0.0115	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—SPP1—nephrolithiasis	0.00612	0.0111	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—RGS14—nephrolithiasis	0.00573	0.0104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00556	0.0101	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—SPP1—nephrolithiasis	0.00508	0.00922	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—DGKH—nephrolithiasis	0.00426	0.00774	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ADCY10—nephrolithiasis	0.00398	0.00723	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SLC7A9—nephrolithiasis	0.00388	0.00704	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—DGKH—nephrolithiasis	0.00388	0.00704	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—DGKH—nephrolithiasis	0.00387	0.00703	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SLC26A1—nephrolithiasis	0.00367	0.00666	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—RGS14—nephrolithiasis	0.00363	0.00658	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RGS14—nephrolithiasis	0.00339	0.00615	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—RGS14—nephrolithiasis	0.00329	0.00598	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ATP6V0A4—nephrolithiasis	0.00327	0.00593	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00308	0.0056	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—SPP1—nephrolithiasis	0.00292	0.00529	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—PTH—nephrolithiasis	0.00282	0.00512	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CHRM3—nephrolithiasis	0.0028	0.00508	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PTH—nephrolithiasis	0.00256	0.00465	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—DGKH—nephrolithiasis	0.00245	0.00445	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GRHPR—nephrolithiasis	0.00233	0.00422	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00229	0.00415	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ADCY10—nephrolithiasis	0.00229	0.00415	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—DGKH—nephrolithiasis	0.00229	0.00415	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—DGKH—nephrolithiasis	0.00222	0.00404	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—SPP1—nephrolithiasis	0.00217	0.00393	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SLC26A1—nephrolithiasis	0.00211	0.00382	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AGXT—nephrolithiasis	0.00207	0.00377	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RGS14—nephrolithiasis	0.00195	0.00353	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ATP6V0A4—nephrolithiasis	0.00188	0.00341	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00177	0.00322	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SLC26A1—nephrolithiasis	0.00176	0.0032	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APRT—nephrolithiasis	0.00176	0.0032	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CHRM3—nephrolithiasis	0.00165	0.003	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PTH—nephrolithiasis	0.00162	0.00294	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CHRM3—nephrolithiasis	0.00161	0.00292	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PTH—nephrolithiasis	0.00151	0.00275	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PTH—nephrolithiasis	0.00147	0.00267	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—DGKH—nephrolithiasis	0.00131	0.00239	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00131	0.00239	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AQP1—nephrolithiasis	0.00126	0.00228	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CHRM3—nephrolithiasis	0.00114	0.00206	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CHRM3—nephrolithiasis	0.00095	0.00173	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTH—nephrolithiasis	0.000869	0.00158	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SPP1—nephrolithiasis	0.000759	0.00138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SPP1—nephrolithiasis	0.000436	0.000792	CbGpPWpGaD
